Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Localized dead bone, a potential hint to an underlying condition.

Cleveland Clinic journal of medicine·2026
Same author

Pseudocellulitis, a vague term for a specific diagnostic challenge.

Cleveland Clinic journal of medicine·2026
Same author

'Even when the wound is healed, the scar remains'.

Cleveland Clinic journal of medicine·2026
Same author

'All that wheezes is not asthma'-a reminder that the physical examination.

Cleveland Clinic journal of medicine·2026
Same author

Getting stuck on a name: An example of an eponymous syndrome.

Cleveland Clinic journal of medicine·2026
Same author

Our Peer Reviewers for 2025.

Cleveland Clinic journal of medicine·2026

Related Experiment Videos

[Cardiovascular disorders and rheumatic disease].

Alexandra Villa-Forte1, Brian F Mandell

  • 1Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, Ohio, USA. villaa@ccf.org

Revista Espanola De Cardiologia
|July 19, 2011
PubMed
Summary

Cardiovascular disease is common in rheumatic conditions, affecting heart structures and potentially causing death. Early recognition and aggressive inflammation control are crucial for managing cardiac risks in these patients.

Related Experiment Videos

Area of Science:

  • Rheumatology
  • Cardiology
  • Immunology

Context:

  • Systemic rheumatic conditions frequently involve the heart, often unrecognized.
  • Cardiac manifestations range from subclinical to severe, impacting morbidity and mortality.
  • Premature atherosclerosis is a growing concern in systemic lupus erythematosus and rheumatoid arthritis.

Purpose:

  • To highlight the prevalence and significance of cardiac involvement in rheumatic diseases.
  • To emphasize the need for early diagnosis and tailored treatment strategies.
  • To discuss the role of inflammation in premature atherosclerosis and ischemic heart disease.

Summary:

  • Cardiovascular disease is a common complication of systemic rheumatic conditions, affecting all cardiac structures.
  • Manifestations require prompt recognition and can necessitate aggressive immunosuppressive therapy.
  • Premature atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis increases coronary death risk.

Impact:

  • Early detection and treatment of cardiac disease improve outcomes in rheumatic patients.
  • Aggressive control of systemic inflammation may reduce ischemic heart disease risk.
  • Further guidelines are needed for ischemic heart disease prevention in this population, focusing on traditional risk factors.